@FierceBiotech: Check out FierceBiotech's FDA Approvals of 2011 Slideshow. Report | Follow @FierceBiotech
@JohnCFierce: Biogen CFO mulls dividend--eventually. My bet is they want to use their $3B in cash for deals. More | Follow @JohnCFierce
@FierceMedDev: Device Makers Said to Double FDA Fees to Produce Faster Reviews--Bloomberg. Article | Follow @FierceMedDev
@MarkHFierce: How to better detect genes linked to cancer? A liquid laser, it seems. If it is safe for the patient, then why not? Story | Follow @MarkHFierce
> Biogen Idec CFO Paul Clancy grabbed a headline with his thoughts on the possibility of paying a dividend with some of the $3.1 billion cash on hand. Biogen ($BIIB) has to balance demands for the cash, from new deals, to buybacks and a possible dividend. "We always get this question as either/or," Clancy tells Bloomberg. "The reality is it's a mixture of all, potentially." Story
> Shares of Ardea Biosciences ($RDEA) slipped this morning when it priced an offering designed to raise $144 million to back a late-stage drug study. Release
> In an update, AcelRx Pharmaceuticals ($ACRX) says that the two remaining items required by the FDA prior to the initiation of the Phase III study for ARX-01 are "progressing." Release
@FiercePharma: Vertex to offer co-pay assistance, case managers to help Kalydeco patients cover the $294K cost--WSJ. News | Follow @FiercePharma
> Pfizer pulls mixed-up contraceptive pills. News
> What will Dendreon's new chief do about Provenge? More
> FDA finds puppies and moths not guilty of DTC interference. Story
Drug Delivery News
> Impax licenses U.S. rights to three versions of AstraZeneca migraine drug. News
> AMT's Glybera, delivered through virus, faces Euro reg delay. More
> Takeda abandons Euro rights to Durect's controlled-release pain drug. Story
> New drug delivery system slows water filtration, displaces air. Article
> Amylin gets FDA OK for weekly diabetes drug Bydureon. News
> Nanotech transforms cyclosporine into safer transplant drug. Item
Medical Device News
> ConforMis nails $89M for iTotal knee manufacturing + launch. Article
> Roche will nominate Illumina board candidates. Item
> CartiHeal scores $5M ahead of 2013 product launch. Story
Biomarkers News
> Alzheimer's biomarkers panel not clear-cut after all. News
> Genetic test could up outcomes after lung cancer surgery. Article
> MRS can detect brain tumor biomarker. Item
> NINDS is close to launching its first NeuroNEXT neurobiomarkers study. Story
> Markers from breast could predict weight loss surgery outcome. More
And Finally... A new study says that the norovirus was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period. Release